Chronic Hepatitis C Virus Infection: Making the Decision to Treat

We are pleased to announce the availability of a new online continuing medical education (CME) program for physicians titled Chronic Hepatitis C Virus (HCV) Infection: Making the Decision to Treat.  The program is provided by Duke University School of Medicine and Medscape in collaboration with the American Liver Foundation.

The program features HCV experts including Andrew Muir, MD (member of our National Medical Advisory Committee) and Kathryn Jack MSN, APRN, FNP-BC (Connecticut Division Board of Directors and frequent adviser to ALF).

(Note:  You will need a Medscape membership.  If you do not have one, you will be given the opportunity to sign up FOR FREE.)


This activity is intended for clinicians engaged in screening, staging, and treating chronic hepatitis C virus (HCV) infection. The goal of this activity is to provide perspective to clinicians on advances in screening, staging, and treatment of HCV infection. Upon completion of this activity, participants will be able to:

1. Identify strategies that have been shown to increase rates of screening for HCV infection
2. Evaluate the role of staging liver disease in patients with chronic HCV infection
3. Select the appropriate treatment regimen for patients with genotype 1 HCV infection


Kristine Schmit, MD, MPH
Medical Instructor
Duke University School of Medicine
Durham, North Carolina


Kathryn E. Jack, MSN, APRN, FNP-BC
Connecticut GI
Hartford, Connecticut



Andrew J. Muir, MD
Associate Professor of Medicine
Director, GI/Hepatology Research
Duke University Medical Center
Durham, North Carolina


Susanna Naggie, MD
Assistant Professor of Medicine
Director, Infectious Diseases Section
Duke University
Durham, North Carolina



This page was created May 2015.